NewSquare Capital LLC Takes Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

NewSquare Capital LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 100 shares of the medical equipment provider’s stock, valued at approximately $44,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Burns J W & Co. Inc. NY lifted its position in Intuitive Surgical by 23.3% during the 2nd quarter. Burns J W & Co. Inc. NY now owns 9,037 shares of the medical equipment provider’s stock worth $4,020,000 after acquiring an additional 1,708 shares in the last quarter. Vicus Capital increased its holdings in Intuitive Surgical by 25.1% during the 2nd quarter. Vicus Capital now owns 1,127 shares of the medical equipment provider’s stock worth $501,000 after purchasing an additional 226 shares during the last quarter. KG&L Capital Management LLC increased its holdings in shares of Intuitive Surgical by 59.6% in the 2nd quarter. KG&L Capital Management LLC now owns 1,181 shares of the medical equipment provider’s stock valued at $525,000 after acquiring an additional 441 shares during the last quarter. Fifth Third Wealth Advisors LLC grew its stake in shares of Intuitive Surgical by 257.6% in the second quarter. Fifth Third Wealth Advisors LLC now owns 4,288 shares of the medical equipment provider’s stock worth $1,908,000 after purchasing an additional 3,089 shares in the last quarter. Finally, Prossimo Advisors LLC bought a new position in Intuitive Surgical during the second quarter valued at about $218,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on ISRG. Robert W. Baird increased their price objective on Intuitive Surgical from $487.00 to $503.00 and gave the stock an “outperform” rating in a research note on Friday, July 19th. Citigroup raised their target price on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a report on Thursday. Evercore ISI cut their target price on Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating for the company in a research report on Friday, July 19th. Stifel Nicolaus lifted their price objective on Intuitive Surgical from $430.00 to $475.00 and gave the company a “buy” rating in a research report on Friday, July 19th. Finally, Piper Sandler lifted their price objective on Intuitive Surgical from $490.00 to $495.00 and gave the company an “overweight” rating in a research report on Friday, July 19th. Six analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $444.70.

Intuitive Surgical Stock Up 0.8 %

Shares of Intuitive Surgical stock traded up $3.70 during trading on Thursday, reaching $491.12. 582,047 shares of the company were exchanged, compared to its average volume of 1,535,841. Intuitive Surgical, Inc. has a twelve month low of $254.85 and a twelve month high of $491.83. The business has a 50-day moving average price of $446.95 and a 200-day moving average price of $409.81. The firm has a market capitalization of $174.20 billion, a price-to-earnings ratio of 88.43, a P/E/G ratio of 4.97 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The firm had revenue of $2.01 billion during the quarter, compared to analysts’ expectations of $1.97 billion. During the same period in the previous year, the firm earned $1.18 earnings per share. The company’s revenue was up 14.5% on a year-over-year basis. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

Insider Buying and Selling

In other Intuitive Surgical news, Director Craig H. Barratt sold 2,496 shares of the stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $402.89, for a total transaction of $1,005,613.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Intuitive Surgical news, EVP Robert Desantis sold 584 shares of the stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $404.41, for a total transaction of $236,175.44. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,226,681.46. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Craig H. Barratt sold 2,496 shares of the firm’s stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $402.89, for a total value of $1,005,613.44. The disclosure for this sale can be found here. Insiders sold a total of 15,309 shares of company stock valued at $6,642,470 in the last three months. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.